[On Demand]
By reading the genetic code, we classify the main drugs concerning the behavior of the patient's organism when using them. This has transformed the lives of thousands of people around the world, allowing them to find the ideal medicine and dosage for their genetic profile.
We arose as a startup and have emerged in Brazil as a leading company in pharmacogenetics. We are proud to be a national reference in this very innovative area. Today we are focused on a model aimed at treating diseases of the Central Nervous Systems, such as depression, anxiety, bipolarity, and ADHD, but our plan is quite bold and new analysis panels are under development to take pharmacogenetics to other medical specialties.